Skip to main content

MoneyWorks4Me

Zydus Lifesciences informs about press release

11 Nov 2025 Evaluate
Zydus Lifesciences has informed that it enclosed a copy of press release dated November 11, 2025, titled ‘Zydus receives approval from China’s NMPA for Venlafaxine Extended-Release Capsules, 75 mg and 150 mg’.

The above information is a part of company’s filings submitted to BSE.
Peers
Company Name CMP
Sun Pharma. Inds. 1905.00
Dr. Reddys Labs. 1385.00
Cipla 1406.00
Lupin 2012.00
Zydus Lifesciences 1213.05
View more..